✦ LIBER ✦

Sarcomas in TP53 germline mutation carriers : A review of the IARC TP53 database

✍ Scribed by Simona Ognjanovic; Magali Olivier; Tracy L. Bergemann; Pierre Hainaut

Book ID: 102807028
Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 1004 KB
Volume: 118
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.26390

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Genotype and phenotype in carriers of ge

Genotype and phenotype in carriers of germline TP53 mutations

✍ Varley, Jenny; Evans, Gareth; Birch, Jillian; Kelsey, Anna 📂 Article 📅 2001 🏛 Nature Publishing Group 🌐 English ⚖ 39 KB

Impact of mutant p53 functional properti

Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database

✍ Audrey Petitjean; Ewy Mathe; Shunsuke Kato; Chikashi Ishioka; Sean V. Tavtigian; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 270 KB

The tumor suppressor gene TP53 is frequently mutated in human cancers. More than 75% of all mutations are missense substitutions that have been extensively analyzed in various yeast and human cell assays. The International Agency for Research on Cancer (IARC) TP53 database (www-p53.iarc.fr) compiles

Reassessment of the TP53 mutation databa

Reassessment of the TP53 mutation database in human disease by data mining with a library of TP53 missense mutations

✍ Thierry Soussi; Shunsuke Kato; Pierre P. Levy; Chikashi Ishioka 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 436 KB 👁 2 views

## Communicated by A. Jamie Cuticchia TP53 alteration is the most frequent genetic alteration found in human cancers. To date, more than 15,000 tumors with TP53 mutations have been published, leading to the description of more than 1,500 different TP53 mutants (http://p53.curie.fr). The frequency o

The IARC TP53 database: New online mutat

The IARC TP53 database: New online mutation analysis and recommendations to users

✍ Magali Olivier; Ros Eeles; Monica Hollstein; Mohammed A. Khan; Curtis C. Harris; 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 392 KB

Communicated by Richard G.H. Cotton Mutations in the tumor suppressor gene TP53 are frequent in most human cancers. Comparison of the mutation patterns in different cancers may reveal clues on the natural history of the disease. Over the past 10 years, several databases of TP53 mutations have been d

Emergence of secondary acute leukemia in

Emergence of secondary acute leukemia in a patient treated for osteosarcoma: implications of germline TP53 mutations

✍ Panizo, Carlos; Patiño, Ana; Calasanz, José; Rifón, José; Sierrasesumaga, Luis; 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB 👁 3 views

Background. Secondary leukemia and myelodysplastic syndromes have been reported in patients following treatment for a wide range of neoplastic disorders. However, second malignancies after chemotherapy and/or irradiation for osteosarcoma are unusual. Procedure. We report the case of a 15-yearold gi

Telomere length in peripheral blood cell

Telomere length in peripheral blood cells of germline TP53 mutation carriers is shorter than that of normal individuals of corresponding age

✍ Marie Trkova; Kamila Prochazkova; Vera Krutilkova; David Sumerauer; Zdenek Sedla 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 185 KB

## Abstract ## BACKGROUND. A decrease in the age at cancer onset and increase in cancer incidence in successive generations in Li‐Fraumeni syndrome (LFS) families with germline __TP53__ mutations have been previously described. In the current study a possible relation was analyzed between telomere